seventy-six consecutive neutropenic patients with hematologic malignancies , admitted to the `` '' department of hematology '' '' of rome between march and september 1986 , were randomly assigned to receive either piperacillin ( 300 mg/kg in four divided doses ) or ceftazidime ( 100 mg/kg in four divided doses ) plus amikacin ( 15 mg/kg in two divided doses ) whenever they developed a febrile episode ( temperature greater than 38 degrees c thrice over 12 hours , not related to drugs or transfusions , or else temperature greater than 38.5 degrees c ) .
C0007559
r ceftazidi
C0015967
a febri